147 related articles for article (PubMed ID: 21682097)
1. In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method.
Skóra M; Macura AB
Wiad Parazytol; 2011; 57(2):111-6. PubMed ID: 21682097
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.
Skóra M; Macura AB; Bulanda M
Med Mycol; 2014 Oct; 52(7):723-7. PubMed ID: 25049036
[TBL] [Abstract][Full Text] [Related]
3. [Antifungal susceptibility of clinical isolates of Scopulariopsis species].
Odero V; García-Agudo L; Guerrero I; Aznar P; García-Martos P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2014 Mar; 27(1):17-21. PubMed ID: 24676237
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
[TBL] [Abstract][Full Text] [Related]
5. [Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].
Carrillo-Muñoz AJ; Santos P; del Valle O; Casals JB; Quindós G
Rev Esp Quimioter; 2004 Sep; 17(3):244-9. PubMed ID: 15619653
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Skóra M; Bulanda M; Jagielski T
Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis].
Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
Rev Esp Quimioter; 2015 Aug; 28(4):210-3. PubMed ID: 26200030
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
[TBL] [Abstract][Full Text] [Related]
9. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
Carrillo-Muñoz AJ; Cárdenes CD; Carrillo-Orive B; Rodríguez V; Del Valle O; Casals JB; Ezkurra PA; Quindós G
Rev Iberoam Micol; 2005 Jun; 22(2):110-3. PubMed ID: 16107170
[TBL] [Abstract][Full Text] [Related]
11. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzón A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2003 Jul; 47(7):2339-41. PubMed ID: 12821493
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibility of dematiaceous fungi to ten antifungal drugs using an agar diffusion test].
Cermeño-Vivas JR; Torresrodríguez JM
Rev Iberoam Micol; 2001 Sep; 18(3):113-7. PubMed ID: 15487919
[TBL] [Abstract][Full Text] [Related]
13. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Vivas JR; Torres-Rodríguez JM
Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of miconazole against recent Candida strains.
Isham N; Ghannoum MA
Mycoses; 2010 Sep; 53(5):434-7. PubMed ID: 19531099
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
[TBL] [Abstract][Full Text] [Related]
16. Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives.
Polak A; Jäckel A; Noack A; Kappe R
Mycoses; 2004 Jun; 47(5-6):184-92. PubMed ID: 15189181
[TBL] [Abstract][Full Text] [Related]
17. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test].
Buchta V; Navrátilová L; Förstl M; Kubanová P
Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients].
Kurnatowska AK; Kwaśniewska J
Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]